What is Theragenics?
Founded in 1981 and headquartered in Buford, Georgia, Theragenics Corporation operates as a critical manufacturer and distributor of high-precision medical and surgical equipment. The company has carved out a significant market position by providing essential wound closure products, including advanced sutures and specialized surgical tools. Its diverse portfolio serves a wide array of clinical disciplines, ranging from veterinary medicine and urology to cardiology, orthopedics, and plastic surgery. By maintaining a robust supply chain and focusing on high-quality manufacturing standards, Theragenics remains a vital partner for healthcare providers seeking reliable surgical solutions that improve patient outcomes across multiple medical specialties.
How much funding has Theragenics raised?
Theragenics has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Theragenics
PPP
Public-Private Partnership
What's next for Theragenics?
The recent strategic financing positions Theragenics to further optimize its manufacturing infrastructure and expand its distribution reach. As the company navigates the complexities of the modern medical device market, this capital will likely be deployed to enhance production efficiency and support the integration of next-generation surgical technologies. By leveraging its decades of industry expertise, Theragenics is well-positioned to address the evolving demands of the clinical sector, ensuring that its wound closure and surgical product offerings remain at the forefront of medical innovation. Future growth will likely focus on deepening market penetration in its core segments while maintaining the rigorous quality standards that have defined its corporate trajectory since its inception.
See full Theragenics company page
